Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the current market size of the single-cell analysis transcriptomics industry, and what growth rate is it expected to achieve?
The single-cell analysis transcriptomics market size has grown rapidly in recent years. It will grow from $0.97 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing prevalence of chronic and rare diseases, emergence of personalized medicine, increasing demand for high-throughput sequencing, and increasing applications in cancer research.
The single-cell analysis transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $1.74 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growing application in immunology and neurology, increasing use in drug discovery and development, expanding adoption of precision medicine, government initiatives supporting genomics research, and advancement in affordability of sequencing technologies. Major trends in the forecast period include advancements in microfluidics and sequencing platforms, integration of artificial intelligence in data analysis, development of multi-omics approaches, innovations in single-cell isolation techniques, and a growing focus on spatial transcriptomics.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24400&type=smp
What are the major drivers contributing to the growth of the single-cell analysis transcriptomics market?
The increasing adoption of personalized medicine is expected to propel the growth of the single-cell analysis transcriptomics market going forward. Personalized medicine is a medical approach that customizes treatment based on an individual’s genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is due to advances in genetic sequencing, enabling treatments tailored to individual genetic profiles for better effectiveness. Single-cell analysis transcriptomics uncovers individual gene expression profiles, guiding personalized treatments based on a patient’s unique biology. It enhances therapeutic effectiveness, minimizes side effects, and enables early disease diagnosis. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the increasing adoption of personalized medicine drives the growth of the single-cell analysis transcriptomics market.
What are the major market segments driving the growth of the single-cell analysis transcriptomics industry?
The single-cell analysis transcriptomics market covered in this report is segmented –
1) By Component: Equipment, Consumables, Software And Services
2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies
3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training
View The Full Market Report:
What evolving trends are creating new opportunities in the single-cell analysis transcriptomics market?
Major companies operating in the single-cell analysis transcriptomics market are focusing on developing innovative products, such as single-cell RNA sequencing kits, to streamline workflows and enable deeper insights into cellular heterogeneity. A single-cell RNA sequencing kit is a specialized tool to isolate and analyze gene expression at the individual cell level. It allows researchers to uncover cellular diversity and gain insights into complex biological processes. For instance, in June 2022, Fluent BioSciences Inc., a US-based biotechnology company specializing in single-cell analysis and molecular research technologies, launched PIPseq T2 and T20 v3.0 kits. It captures up to 2,000 and 20,000 single cells or nuclei per reaction. It offers sensitive, scalable, and flexible transcriptomic analysis suitable for low-cell diversity studies and large-scale solid tissue profiling. It is also a highly accessible and cost-effective single-cell RNA sequencing kit.
Who are the key market players contributing to the growth of the single-cell analysis transcriptomics industry?
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., Relation Therapeutics Ltd., CYTENA GmbH, Fluent BioSciences
Which regions are leading the growth of the single-cell analysis transcriptomics market globally?
North America was the largest region in the single-cell analysis transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Single-Cell Analysis Transcriptomics Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24400&type=smp
Need Customized Data On Single-Cell Analysis Transcriptomics Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24400&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
